Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 179,078,080
  • Shares Outstanding, K 536,435
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • 60-Month Beta 0.58
  • Price/Sales 6.31
  • Price/Cash Flow 12.56
  • Price/Book 29.97
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 19.72% ( -0.92%)
  • Historical Volatility 23.98%
  • IV Percentile 21%
  • IV Rank 14.47%
  • IV High 38.54% on 08/05/24
  • IV Low 16.53% on 09/01/23
  • Put/Call Vol Ratio 0.42
  • Today's Volume 6,683
  • Volume Avg (30-Day) 11,575
  • Put/Call OI Ratio 1.02
  • Today's Open Interest 172,287
  • Open Int (30-Day) 179,175

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 4.81
  • Number of Estimates 13
  • High Estimate 5.42
  • Low Estimate 1.03
  • Prior Year 4.96
  • Growth Rate Est. (year over year) -3.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
306.59 +8.88%
on 08/07/24
340.89 -2.07%
on 08/01/24
+0.55 (+0.17%)
since 07/30/24
3-Month
295.30 +13.05%
on 06/13/24
346.85 -3.75%
on 07/25/24
+32.83 (+10.91%)
since 05/30/24
52-Week
248.38 +34.40%
on 09/06/23
346.85 -3.75%
on 07/25/24
+74.19 (+28.57%)
since 08/29/23

Most Recent Stories

More News
3 Unstoppable Dividend Stocks to Buy Right Now

These stocks are the A-team for income investors.

ABT : 113.27 (+0.45%)
AMGN : 333.83 (+0.85%)
ABBV : 196.31 (+0.58%)
AMGN Bullish Diagonal Trade Targets a Price of $350 by October 18th

A bullish diagonal spread is an advanced option trade and generally not suitable for beginners, but it can have its place within an option portfolio.

AMGN : 333.83 (+0.85%)
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade

Investors seeking reliable dividend growth want to start with these two members of the Dow Jones Industrial Average.

GS : 510.25 (+0.62%)
AAPL : 229.00 (-0.34%)
$DOWI : 41,563.08 (+0.55%)
AMGN : 333.83 (+0.85%)
JNJ : 165.86 (+0.99%)
This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the Pipeline

Amgen has many growth opportunities ahead, and it also pays a fairly high dividend.

AMGN : 333.83 (+0.85%)
Got the Market Sell-Off Blues? Do These 3 Things Right Now

You aren't powerless in the face of what the market throws at you.

CRSP : 47.72 (+0.36%)
AMGN : 333.83 (+0.85%)
ABT : 113.27 (+0.45%)
Are Wall Street Analysts Bullish on Amgen Stock?

Amgen has outperformed the broader market over the past year, yet Wall Street analysts remain cautiously optimistic about the stock’s prospects.

AMGN : 333.83 (+0.85%)
$SPX : 5,648.40 (+1.01%)
MEDX : 31.92 (+0.02%)
Here's Why Eli Lilly Stock Dropped 12% Last Month

News from a competitor gave investors an unwelcome dose of reality.

LLY : 960.02 (+2.11%)
RHHBY : 42.3300 (+0.69%)
NVO : 139.16 (+1.19%)
PFE : 29.01 (+1.01%)
AMGN : 333.83 (+0.85%)
VKTX : 64.12 (+2.35%)
Stocks Give Up Early Gains as Chip Makers Slide and Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.77%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.16%. US stock...

$SPX : 5,648.40 (+1.01%)
SPY : 563.68 (+0.95%)
$DOWI : 41,563.08 (+0.55%)
DIA : 416.21 (+0.56%)
$IUXX : 19,574.64 (+1.29%)
QQQ : 476.27 (+1.19%)
ZNZ24 : 113-180s (-0.27%)
NVDA : 119.37 (+1.51%)
AVGO : 162.82 (+3.75%)
ARM : 132.88 (+0.72%)
INTC : 22.04 (+9.49%)
MRVL : 76.24 (+9.16%)
Why Amgen Stock Is Down Today Despite Solid Q2 Results

Shares may have been likely to fall no matter what the company reported.

AMGN : 333.83 (+0.85%)
Market Rally Fizzles, Stock Indexes Turn Negative

The S&P 500 Index ($SPX ) (SPY ) today is down -0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.43%. After a strong morning rally,...

$SPX : 5,648.40 (+1.01%)
SPY : 563.68 (+0.95%)
$DOWI : 41,563.08 (+0.55%)
DIA : 416.21 (+0.56%)
$IUXX : 19,574.64 (+1.29%)
QQQ : 476.27 (+1.19%)
ZNZ24 : 113-180s (-0.27%)
NFLX : 701.35 (+1.28%)
AAPL : 229.00 (-0.34%)
AMZN : 178.50 (+3.71%)
GOOGL : 163.38 (+0.99%)
MSFT : 417.14 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 341.58
2nd Resistance Point 338.62
1st Resistance Point 336.23
Last Price 333.83
1st Support Level 330.87
2nd Support Level 327.91
3rd Support Level 325.51

See More

52-Week High 346.85
Last Price 333.83
Fibonacci 61.8% 309.23
Fibonacci 50% 297.61
Fibonacci 38.2% 286.00
52-Week Low 248.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar